Recommendations made by the PBAC – March 2022

Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) in March 2022 relating to the listing of drugs on the Pharmaceutical Benefits Scheme (PBS).

• March 2022 – PBAC Outcomes (PDF 588KB) – (Word 127KB)
• March 2022 – Consideration of DUSC Report (PDF 198KB) – (Word 24KB)